Suchergebnisse - "Ader, Florence"

PubPharm (9)

1

Management of pharmacovigilance during the COVID-19 pandemic crisis by the safety department of an academic sponsor : Lessons learnt and challenges from the EU DisCoVeRy clinical trial

enthalten in: Pharmacology research & perspectives | 2023

von Mercier, N. | Belhadi, D. | DeChanet, A. | +122

2

An open-label randomized, controlled trial of the effect of lopinavir and ritonavir, lopinavir and ritonavir plus interferon-β-1a, and hydroxychloroquine in hospitalized patients with COVID-19 : final results

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2022

von Ader, F. | DisCoVeRy Study Group

3

Remdesivir and three other drugs for hospitalised patients with COVID-19 : final results of the WHO Solidarity randomised trial and updated meta-analyses

enthalten in: Lancet (London, England) | 2022

von WHO Solidarity Trial Consortium | Pan, H. | Peto, R. | +98

CommentIn: Lancet. 2022 May 21;399(10339):1918-1920. - PMID 35512729

4

An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2021

von Ader, F. | Peiffer-Smadja, N. | Poissy, J. | +56

CommentIn: Clin Microbiol Infect. 2021 Dec;27(12):1716-1717. - PMID 34508887

5

Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results

enthalten in: The New England journal of medicine | 2021

von WHO Solidarity Trial Consortium | Pan, H. | Peto, R. | +172

CommentIn: N Engl J Med. 2021 Feb 11;384(6):576-577. - PMID 33264557

6

Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial-authors' response

enthalten in: The Journal of antimicrobial chemotherapy | 2021

von Lê, M. | Peiffer-Smadja, N. | Guedj, J. | +50

CommentOn: J Antimicrob Chemother. 2021 Jan 1;76(1):276-277. - PMID 32766679

7

Protocol for the DisCoVeRy trial : multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults

enthalten in: BMJ open | 2020

von Ader, F. | Discovery French Trial Management Team | Yazdanpanah, Y. | +49

8

Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial

enthalten in: The Journal of antimicrobial chemotherapy | 2020

von Lê, M. | Peiffer-Smadja, N. | Guedj, J. | +5

CommentIn: J Antimicrob Chemother. 2021 Jan 1;76(1):276-277. - PMID 32766679

9

Disappearance of FDG uptake on PET scan after antimicrobial therapy could help for the diagnosis of Coxiella burnetii spondylodiscitis

enthalten in: BMJ case reports | 2016

von Gaudé, M. | Julien, S. | Laurent, F. | +50

1
[1]